<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>AMA Publishing Group: Pacemakers/Defibrillators Topic Collection</title>
    <link>http://pubs.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Wed, 15 May 2013 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 14 May 2013 20:45:31 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@pubs.jamanetwork.com</managingEditor>
    <webMaster>webmaster@pubs.jamanetwork.com</webMaster>
    <item>
      <title>Association of Single- vs Dual-Chamber ICDs With Mortality, Readmissions, and Complications Among Patients Receiving an ICD for Primary Prevention Dual Chamber ICDs, Mortality, and Complications </title>
      <link>http://pubs.jamanetwork.com/article.aspx?articleID=1687578</link>
      <pubDate>Wed, 15 May 2013 00:00:00 GMT</pubDate>
      <author>Peterson PN, Varosy PD, Heidenreich PA, et al. </author>
      <description>&lt;span class="paragraphSection"&gt;&lt;div class="boxTitle"&gt;Importance&lt;/div&gt;Randomized trials of implantable cardioverter-defibrillators (ICDs) for primary prevention predominantly used single-chamber devices. In clinical practice, patients often receive dual-chamber ICDs, even without clear indications for pacing. The outcomes of dual- vs single-chamber devices are uncertain.&lt;div class="boxTitle"&gt;Objective&lt;/div&gt;To compare outcomes of single- and dual-chamber ICDs for primary prevention of sudden cardiac death.&lt;div class="boxTitle"&gt;Design, Setting, and Participants&lt;/div&gt;Retrospective cohort study of admissions in the National Cardiovascular Data Registry's (NCDR) ICD registry from 2006-2009 that could be linked to Centers for Medicare &amp; Medicaid Services fee-for-service Medicare claims data. Patients were included if they received an ICD for primary prevention and did not have a documented indication for pacing.&lt;div class="boxTitle"&gt;Main Outcomes and Measures&lt;/div&gt;Adjusted risks of 1-year mortality, all-cause readmission, heart failure readmission, and device-related complications within 90 days were estimated with propensity-score matching based on patient, clinician, and hospital factors.&lt;div class="boxTitle"&gt;Results&lt;/div&gt;Among 32 034 patients, 12 246 (38%) received a single-chamber device and 19 788 (62%) received a dual-chamber device. In a propensity-matched cohort, rates of complications were lower for single-chamber devices (3.51% vs 4.72%; P &lt; .001; risk difference, −1.20 [95% CI, −1.72 to −0.69]), but device type was not significantly associated with 1-year mortality (unadjusted rate, 9.85% vs 9.77%; hazard ratio [HR], 0.99 [95% CI, 0.91 to 1.07]; P = .79), 1-year all-cause hospitalization (unadjusted rate, 43.86% vs 44.83%; HR, 1.00 [95% CI, 0.97-1.04]; P = .82), or hospitalization for heart failure (unadjusted rate, 14.73% vs 15.38%; HR, 1.05 [95% CI, 0.99-1.12]; P = .19).&lt;div class="boxTitle"&gt;Conclusions and Relevance&lt;/div&gt;Among patients receiving an ICD for primary prevention without indications for pacing, the use of a dual-chamber device compared with a single-chamber device was associated with a higher risk of device-related complications and similar 1-year mortality and hospitalization outcomes. Reasons for preferentially using dual-chamber ICDs in this setting remains unclear.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">309</prism:volume>
      <prism:number xmlns:prism="prism">19</prism:number>
      <prism:startingPage xmlns:prism="prism">2025</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">2034</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jama.2013.4982</prism:doi>
      <guid>http://pubs.jamanetwork.com/article.aspx?articleID=1687578</guid>
    </item>
  </channel>
</rss>